Prolucent ®, a leading provider of enterprise-wide healthcare workforce optimization software and services, today announced that A1 Health Ventures Director Joe Greskoviak has joined Prolucent’s Board of Directors with the close of $4 million in funding by A1 Health Ventures. A1 Health Ventures is a newly launched venture capital firm developed jointly between Abundant Venture Partners and First Trust Capital Partners. A1 Health Ventures invests in transformational technology solutions with the proven ability to improve operations and financial performance for healthcare providers.
Greskoviak is a highly accomplished and regarded healthcare executive who also serves as Partner at Abundant Venture Partners. With a distinguished career spanning more than three decades, Greskoviak has succeeded in several high visibility executive positions, most recently serving as the CEO of Press Ganey where he drove remarkable growth. He was instrumental in the company’s initial public offering, as well as two private equity transactions. Greskoviak has an impressive record of operating, developing, and investing in healthcare companies.
The new capital will fuel Prolucent’s continued product innovation to help healthcare providers nationwide gain control of labor costs, build a better-balanced workforce, and meet the demands of a continually changing labor market. With labor expenses accounting for more than 50 percent of hospitals’ total expenses, streamlining workforce management can have a tremendous impact on operating margins while fostering a more cohesive culture of collaboration.
“We are excited to partner with Joe and A1 to leverage their industry expertise and resources to enable us to further expand upon our mission to develop workforce optimization solutions that will make a significant impact on healthcare labor cost containment strategies,” stated Bruce Springer, CEO of Prolucent. “Joe’s business vision and operational know-how will be tremendously valuable as we embark on our next phase of growth.”
Prolucent develops end-to-end solutions for optimizing healthcare’s workforce needs using technology, artificial intelligence, and advanced analytics to improve the recruitment, utilization, and cost of healthcare labor. Prolucent’s Liquid Compass® workforce management platform integrates a talent marketplace, advanced analytics, and a vendor-neutral VMS to meet both the demand and supply of labor using a single platform. The AI-driven platform centralizes the management of all labor types — including core staff, flexible staff, and external contingent staff — to optimize staffing effectiveness and create sustainable labor cost savings.
Greskoviak stated, “I am excited to become a member of Prolucent’s Board of Directors as I believe their offerings are truly transformational and can deliver savings well beyond the traditional approach to workforce management. With their strong management team, unified technology platform, and focus on the most significant challenges faced by healthcare providers, Prolucent aligns well with A1’s investment thesis. Our strategic health system investors confirm that workforce optimization solutions are a leading priority for the healthcare industry, and Prolucent’s proprietary technology platform and commitment to innovation position the company well to meet this growing demand.”
About Prolucent
Prolucent empowers flexible workforce optimization solutions, streamlining the way healthcare meets total workforce needs with end-to-end solutions that provide cost effective and sustainable answers to healthcare’s workforce challenges. For more information, please visit www.prolucent.com.
The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.
